Visa Inc. (NYSE: V) reported net revenue of $6.6 billion for the fourth quarter of 2021, up 29% year-over-year.
GAAP net income rose 68% to $3.6 billion, or $1.65 per share. Adjusted net income rose 42% to $3.5 billion, or $1.62 per share.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these conditions. Biogen (BIIB) has a strong portfolio of
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing a slowdown in North American sales. Meanwhile, earnings
Goldman Sachs (GS) exceeded analysts’ expectations, as investment banking revenue surged nearly 90%. Goldman market research report covers key aspects about the firm including company profile, financial highlights and key